Hospital-Treated Gram-Negative Infections – Epidemiology – Mature Markets

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
DRG Epidemiology provides at least ten years of forecast data for the following hospital-treated infection patient populations:
Diagnosed HCAP events due to E.coli
Diagnosed BSI events due to Klebsiella
Diagnosed BSI events due to E.coli
Diagnosed BSI events due to Pseudomonas
Diagnosed BSI events due to other gram-negative
Diagnosed cIAI events due to E.coli
Diagnosed cIAI events due to Pseudomonas
… and many more (details available on request).
Note: Coverage may vary by country and region.

Table of contents

  • Hospital-Treated Gram-Negative Infections - Epidemiology - Mature Markets
    • Introduction
      • Key Findings
        • Diagnosed Event Rate of UTIs per 1,000 per Year Among People of All Ages in 2021 and 2031
        • Relative Sizes of the Factors Contributing to the Trend in Diagnosed Events of UTIs over the Next Ten Yearsttttttttt
        • Number of Additional Diagnosed Events of UTIs Incurred Over the Period 2021-2031 Across the Countries Under Study Due to Trends in Risk
      • Epidemiology Data
      • Methods
        • Diagnosed Urinary Tract Infection Events
        • Diagnosed Bloodstream Infection Events
        • Diagnosed Nosocomial Pneumonia Events
        • Diagnosed Complicated Intra-Abdominal Infection Events
        • Diagnosed Surgical-Site Infection Events
        • Diagnosed Complicated Skin and Skin Structure Infection Events
        • Pathogen Distribution of Urinary Tract Infections
        • Pathogen Distribution of Nosocomial Pneumonia
        • Pathogen Distribution of Bloodstream Infections
        • Pathogen Distribution of Complicated Intra-Abdominal Infections
        • Pathogen Distribution of Surgical-Site Infections and Complicated Skin and Skin Structure Infections
        • Drug-Treated Events
        • Antimicrobial Resistance to Extended-Spectrum Cephalosporins
        • Antimicrobial Resistance to Carbapenems
        • Antimicrobial Resistance to Fluoroquinolones
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Hospital-Treated Gram-Negative Infections
          • Studies Excluded in the Analysis of Hospital-Treated Gram-Negative Infections
        • Risk/Protective Factors
          • Risk/Protective Factors for Hospital-Treated Gram-Negative Infections
        • Bibliography
        • Glossary
        • Abbreviations